Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 16, 2009 08:15 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx Board of Directors Authorizes Multimillion Dollar Expansion of Its FDA Licensed Manufacturing Facilities

PHILADELPHIA, Sept. 16, 2009 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) (the "Company") today announced that its Board of Directors has just approved up to $4.4 Million (U.S.) for...
September 02, 2009 10:00 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx Biopharma Presents At the Rodman Healthcare Conference

PHILADELPHIA, Sept. 2, 2009 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) (the "Company"), today announced that the Company will participate in the Rodman & Renshaw 11th Annual...
September 02, 2009 09:00 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx Biopharma Announces Cancellation of Adjourned Stockholders' Meeting

PHILADELPHIA, Sept. 2, 2009 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE AMEX:HEB) announced today that insufficient votes were obtained for passage of proposal no. 3 contained in the proxy for the...
August 10, 2009 07:15 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx Biopharma, Inc. 2nd Quarter 2009 Financial Results

PHILADELPHIA, Aug. 10, 2009 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) announced its financial results for the three months ended June 30, 2009. The net loss (including non-cash...
July 22, 2009 07:00 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx Biopharma Announces Further Adjournment On Proposal Number 3 From the 2009 Annual Meeting of Stockholders

PHILADELPHIA, July 22, 2009 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE AMEX:HEB) announced today that the Company will extend the time allowed for stockholders to vote on proposal number 3...
July 20, 2009 08:00 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx Biopharma to Provide Update On Global Pandemic Influenza Prevention / Treatment Initiatives

PHILADELPHIA, July 20, 2009 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE AMEX:HEB) will provide an update on its Influenza research initiatives via teleconference on Wednesday, July 22, 2009, at...
June 24, 2009 17:04 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx Biopharma Reports On Annual Stockholder Meeting

PHILADELPHIA, June 24, 2009 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE AMEX:HEB) announced that it held its 2009 Annual Meeting of Stockholders. Final voting results will be included in an 8-K to...
June 17, 2009 16:50 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx Biopharma Appoints Robert Dickey IV to the New Position of Senior Vice President

PHILADELPHIA, June 17, 2009 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE AMEX:HEB) announced today the appointment of Robert Dickey IV as Senior Vice President. This is a newly created role at...
June 16, 2009 12:20 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx Biopharma Provides Corporate Update On Various Strategic Initiatives

PHILADELPHIA, June 16, 2009 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE AMEX:HEB) announced that a corporate update on operations has been provided on June 12, 2009 and can be accessed at...
June 12, 2009 09:29 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx's Collaborative Partner in Japan, Biken Corp., Expands Production Capacity for Swine/Avian Flu Vaccines

PHILADELPHIA, June 12, 2009 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE AMEX:HEB) announced today that its collaborative influenza vaccine development partner in Japan, Biken, has decided to expand...